• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


5.500 EUR 0.255 4.86%

As of 11:36:00 ET on 12/19/2014.

Company Profile for MagForce AG (MF6)

Magforce AG develops medical technologies. The Company specializes in nanocancer therapy for treatment of cancerous tumors. Magforce's treatment uses nanoparticles containing ironoxide, which are injected into solid tumors in a procedure similar to a biopsy.

Contact Information

MagForce AG

Max-Planck-Strasse 3
Berlin, 12489
Phone: 49-30-308-380-0
Fax: 49-30-308-380-99

Key Executives for MagForce AG (MF6)

Benjamin J Lipps "Ben"Chairman-Mgmt Board/CEOChristian Von VolkmannCFO/Member-Mgmt Board
Hoda TawfikCOO/CMO:Therapy Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil